Boston keratoprosthesis for the treatment of corneal blindness clinical effectiveness and cost-effectiveness
This Rapid Response report aims to review the clinical and cost-effectiveness of Boston Type 1 (KPro) keratoprosthesis for the treatment of corneal blindness
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2016, 22 April 2016
|
| Series: | Rapid response report: summary with critical appraisal
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | This Rapid Response report aims to review the clinical and cost-effectiveness of Boston Type 1 (KPro) keratoprosthesis for the treatment of corneal blindness |
|---|---|
| Item Description: | "CADTH Rapid Response Service." |
| Physical Description: | 1 PDF file (16 pages) illustration |